Research teams led by Massachusetts General Hospital Cancer Center investigators are publishing two important studies regarding use of the targeted cancer drug crizotinib for treatment of advanced lung cancer driven by specific genetic mutations.
Fuente : http://www.eurekalert.org/pub_releases/2013-06/mgh...
Fuente : http://www.eurekalert.org/pub_releases/2013-06/mgh...